Vimarsana
Biggest News Aggregation in the World

Page 4 - Tim Chiang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Chiang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Chiang Today - Breaking & Trending Today

Seurat Technologies Raises $21M to Decarbonize Manufacturing - Vimarsana News

Seurat Technologies Raises $21M to Decarbonize Manufacturing

/PRNewswire/ -- Seurat Technologies, the 3D metal printing leader that is making manufacturing better for people and the planet, today announced it has closed...

Ironwood Pharmaceuticals, inc (IRWD) Q3 2021 Earnings Call Transcript - Vimarsana News

Ironwood Pharmaceuticals, inc (IRWD) Q3 2021 Earnings Call Transcript

IRWD earnings call for the period ending September 30, 2021.

Source: fool.com
BioDelivery Sciences International, inc (BDSI) Q3 2021 Earnings Call Transcript - Vimarsana News

BioDelivery Sciences International, inc (BDSI) Q3 2021 Earnings Call Transcript

BDSI earnings call for the period ending October 31, 2021.

Source: fool.com
IDEAYA Biosciences to Participate in Investor Conferences in November 2021 - Vimarsana News

IDEAYA Biosciences to Participate in Investor Conferences in November 2021

/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and...

Amphastar Pharmaceuticals Inc (AMPH) Q1 2021 Earnings Call Transcript - Vimarsana News

Amphastar Pharmaceuticals Inc (AMPH) Q1 2021 Earnings Call Transcript

Operator 3Greetings. Welcome to the Amphastar Pharmaceuticals Inc. First Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. All statements on this conference call that are not historical are forward-looking statements, including, among other things, statements relating to our expectations regarding future financial performance, backlog, sales and marketing of our products, market size and growth, product development, the timing of FDA filings or approvals, including the DM...

Source: fool.com